# SUPPLEMENTAL READ-ONLY AUDIT REPORT: P012 PRODUCTION ADMISSION PACKET (DELTA AUDIT B2)

**Auditor:** gemini-3.8-flash-high (supplemental read-only corroboration; unexecuted detection audit)  
**Target Directory:** `C:/LAB/Tradingview_LAB_CLEAN/_gemini_packets_20260913/P012_RISK_PACKET_20260914_B`  
**Subject File:** `subject/P012_PRODUCTION_ADMISSION_PACKET.md` (291 lines)  
**Correction Disposition:** `subject/DISPOSITION_FIX1.md`  
**Prior Report:** `prior/GEMINI_AUDIT_1_REPORT.md` (verdict: `REQUEST_CHANGES`, findings F-01..F-09)  

---

## (a) Delta Table: Prior Findings F-01 through F-09

| Finding ID | Severity in Prior Audit | Description | Status | Proof Lines in Corrected Packet (`subject/P012_PRODUCTION_ADMISSION_PACKET.md`) |
|---|---|---|---|---|
| **F-01** | BLOCKING | Conflation of Path D Fee Choice B3 with Funding Effective Interval F-13 | **RESOLVED** | **Lines 49–55**: Explicitly separates Fee B3 from Funding F-13, citing `PATH_D_DECISION_SIGNED_20260912.md:6, 7`, `PATH_D_DECISION_PACKET.md:70, 71, 103`, and `P012_ACCEPTANCE_AMENDMENT_20260913.md:211` (`PD-FUND-START`).<br>**Line 126** (Table B, row F-13): Recommends choosing funding period semantics separately from Fee B3.<br>**Lines 177–178** (Table C): Distinguishes first-authenticated-fill fee boundary from forward funding interval.<br>**Lines 227–241** (Section 6, Questions 4 & 5): Poses funding period semantics (Question 4) and fee interval boundary (Question 5) as separate owner decisions. |
| **F-02** | BLOCKING | Invented citation `03_PRODUCTION_CLOSURE_MATRIX.md:404` & misattribution of rows 24–27 | **RESOLVED** | **Lines 108–110, 137, 163, 274–278**: The non-existent citation `:404` is completely absent. All matrix citations are within lines 7–62 (file length: 66 lines). Rows 24–27 are attributed strictly to `03_PRODUCTION_CLOSURE_MATRIX.md:53` and `P012_ACCEPTANCE_AMENDMENT_20260913.md:395-397` as four retained shared requirements (grouped; per-ID ordering unavailable). |
| **F-03** | BLOCKING | Upgrading open specialist reviewer question to factual assertion ("owner is confirmed as qualified human reviewer") | **RESOLVED** | **Lines 4, 117, 125, 136, 179, 204–206**: The assertion that the owner is confirmed as the qualified reviewer has been removed everywhere. Reviewer identity is framed strictly as an open **WHO** question citing `REVIEW_POLICY.md:73-76`, `PATH_D_DECISION_PACKET.md:164`, and `P012_ACCEPTANCE_AMENDMENT_20260913.md:144, 212`. Line 205 explicitly states: *"name the experienced engineer / qualified record reviewer. If Baris intends to be that person, say so explicitly; the policy is satisfied only if he meets the wording. This is not already decided."* |
| **F-04** | CORRECTION | Citations to external files not staged in packet directory | **RESOLVED** | **Lines 30–35, 70–74, 245–251, 287–290**: Staged copies `sources/DEPLOY_LINUX_README.md` and `sources/MASTER_WORK_PACKAGE_excerpt.md` are present, mapped in `FILE_MAP.md`, and natively verified line-by-line. |
| **F-05** | CORRECTION | Typo in filename `PATH_D_DECISION_DECISION_SIGNED_20260912.md` | **RESOLVED** | **Lines 45, 50, 51, 57, 175, 176, 177, 178, 185, 187, 219, 231, 238, 264**: The string `DECISION_DECISION` is absent; the canonical path `PATH_D_DECISION_SIGNED_20260912.md` is cited throughout. |
| **F-06** | CORRECTION | Pervasive line offsets and wrong-line citations across sources | **RESOLVED** | All 17 previous wrong-line citations (and all other citations in the packet) have been re-verified against the staged copies. Every citation is exact (see full citation table in section (c)). |
| **F-07** | CORRECTION | Cell text paraphrasing and truncation in Tables A and B | **RESOLVED** | **Lines 80–89, 92–101, 114–137, 140–163**: Table A (OPEN-01..10) and Table B (I-1..I-5, C-6..C-12, F-13..F-23, 24–27) quote settled choices and remaining closures verbatim from `03_PRODUCTION_CLOSURE_MATRIX.md` (see section (b)). |
| **F-08** | NIT | Encoding corruption `?1` instead of `>= 1` in Table C | **RESOLVED** | **Lines 49, 176, 228**: Text renders cleanly as `>= 1`. Zero mojibake or UTF-8 corruption remains. |
| **F-09** | NIT | Syntactical mismatch in Owner Decision 1 (answering "Who" with "Yes") | **RESOLVED** | **Lines 204–206**: Question 1 asks *"Who is the qualified human reviewer..."* and recommended answer is who-shaped: *"name the experienced engineer / qualified record reviewer..."* without the mismatched "Yes". |

---

## (b) Row-Completeness Tables for Table A and Table B

### Table A: 10 Section-19 OPEN Rows Completeness Check

| Row | Quoted Settled Choice in Packet (`subject/P012_PRODUCTION_ADMISSION_PACKET.md`) | Quoted Remaining Closure in Packet | Matrix Source Line (`sources/03_PRODUCTION_CLOSURE_MATRIX.md`) | Verbatim Match Status |
|---|---|---|---|---|
| **OPEN-01** | `"Hyperliquid perp BTC from frozen doc set; record APPROVED (add. 16 row 42)"` | `"minimum_quantity: venue publishes none (recorded); **section-16 human review by owner at build acceptance**"` | Line 11 | **EQUAL** (Verbatim) |
| **OPEN-02** | `"STOP_FIRST mandatory same-bar policy (add. 15 row 32)"` | `"Reuse existing bounded fixture evidence; final production applicability/review still required"` | Line 12 | **EQUAL** (Verbatim) |
| **OPEN-03** | `"fee table v1.1 + ADOPTED CLASS MAPPING (add. 16 row 43)"` | `"margin-call/liquidation class CANNOT MAP; rounding/minimum-fee not stated by frozen bytes"` | Line 13 | **EQUAL** (Verbatim) |
| **OPEN-04** | `"`BPS_OF_REFERENCE_V1`, `slippage_bps = 0` explicit zero (add. 15 row 38)"` | `"none listed"` | Line 14 | **EQUAL** (Verbatim) |
| **OPEN-05** | `"funding rules APPROVED + same-timestamp snapshot INCLUDE (add. 16 row 42, 17 row 46)"` | `"Reuse existing bounded fixture evidence; final production applicability/review still required"` | Line 15 | **EQUAL** (Verbatim) |
| **OPEN-06** | `"RETAIN ALL P01-P03/P05-P18/P24-P26; P04 RETIRE, P19 RETIRE, P20 RETAIN, P21 RETIRE-implicitness, P22 STOP_FIRST, P23 N/A (add. 16 row 45)"` | `"Reuse existing bounded fixture evidence; final production applicability/review still required"` | Line 16 | **EQUAL** (Verbatim) |
| **OPEN-07** | `"mapping APPROVED as closure evidence; unmapped fields + deployed-v4 non-materialization = RECORDED INTEGRATION OBLIGATIONS (add. 15 row 41, 16 row 42)"` | `"unmapped funding fields without direct Bridge source"` | Line 17 | **EQUAL** (Verbatim) |
| **OPEN-08** | `"no additional bounds (add. 15 row 33)"` | `"Reuse existing bounded fixture evidence; final production applicability/review still required"` | Line 18 | **EQUAL** (Verbatim) |
| **OPEN-09** | `"additive result/event schema (add. 15 row 34); build authorization = add. 16 T0 path"` | `"Reuse existing bounded fixture evidence; final production applicability/review still required"` | Line 19 | **EQUAL** (Verbatim) |
| **OPEN-10** | `"guards keep GROSS-MINUS-FEES (add. 15 row 35)"` | `"Reuse existing bounded fixture evidence; final production applicability/review still required"` | Line 20 | **EQUAL** (Verbatim) |

*Table A Completeness: 10 of 10 rows present, quoted verbatim from source matrix.*

---

### Table B: 27 Signed Residual Risks Completeness Check

| Risk ID | Quoted Current State / Settled Choice in Packet | Quoted Remaining Closure in Packet | Matrix Source Line (`sources/03_PRODUCTION_CLOSURE_MATRIX.md`) | Verbatim Match Status |
|---|---|---|---|---|
| **I-1** | `"addendum-16 selection applied; admission still refused"` | `"real qualified human review + full admission evidence"` | Line 30 | **EQUAL** (Verbatim) |
| **I-2** | `"scalar `null`; typed policy `HYPERLIQUID_PX_V1` implemented"` | `"Scalar remains null; reuse accepted PR176 typed-policy/precision evidence; formal signed residual not retired. This prep did not rerun that acceptance. No new scalar demand."` | Line 31 | **EQUAL** (Verbatim) |
| **I-3** | `"`null`; `minimum_notional: 10`, `quantity_step: 0.00001`; no quantity floor"` | `"Minimum_quantity remains a distinct unclosed source fact; venue quantity minimum if stated; never infer zero"` | Line 32 | **EQUAL** (Verbatim) |
| **I-4** | `"`human_reviewer: null` (key present)"` | `"real **qualified** human review of completed record"` | Line 33 | **EQUAL** (Verbatim) |
| **I-5** | `"implemented + verified (`source_sha256 = da2bf1fe…`, five sources)"` | `"none"` | Line 34 | **EQUAL** (Verbatim) |
| **C-6** | `"start implemented (`2026-09-06T14:00:30Z`)"` | `"historical tier coverage — Sept-8 snapshot does not prove earlier tier history"` | Line 35 | **EQUAL** (Verbatim) |
| **C-7** | `"KEEP_REFUSED; absence proof attached"` | `"authoritative precision/direction/per-fill scope"` | Line 36 | **EQUAL** (Verbatim) |
| **C-8** | `"KEEP_REFUSED; absence proof"` | `"authoritative applicability/absence + exceptions"` | Line 37 | **EQUAL** (Verbatim) |
| **C-9** | `"KEEP_REFUSED; absence proof"` | `"authoritative minimum/application granularity"` | Line 38 | **EQUAL** (Verbatim) |
| **C-10** | `"collected, not incorporated"` | `"historical coverage + actual fee applicability"` | Line 39 | **EQUAL** (Verbatim) |
| **C-11** | `"CANNOT_MAP refusal (`MARGIN_CALL_LIQUIDATION`)"` | `"complete applicable economic mapping + historical scope"` | Line 40 | **EQUAL** (Verbatim) |
| **C-12** | `"key absent (not null)"` | `"real **qualified** human review"` | Line 41 | **EQUAL** (Verbatim) |
| **F-13** | `"`null`"` | `"complete period + interval semantics"` | Line 42 | **EQUAL** (Verbatim) |
| **F-14** | `"`null`; `REFUSED_MISSING_PRODUCTION_FUNDING_EVENTS`"` | `"complete admissible event series"` | Line 43 | **EQUAL** (Verbatim) |
| **F-15** | `"4 raw stamps (+31–53 ms) collected, not admitted"` | `"payment/interval association"` | Line 44 | **EQUAL** (Verbatim) |
| **F-16** | `"none admitted"` | `"source-bound unique identity + dedup/exact-once"` | Line 45 | **EQUAL** (Verbatim) |
| **F-17** | `"4 rows `0.0000125`, not admitted"` | `"bind authoritative rates to admitted payments"` | Line 46 | **EQUAL** (Verbatim) |
| **F-18** | `"`LONG` rule implemented; no per-event objects"` | `"proven convention onto sourced events"` | Line 47 | **EQUAL** (Verbatim) |
| **F-19** | `"3 samples; no settlement valuation"` | `"authoritative source + defensible per-payment association"` | Line 48 | **EQUAL** (Verbatim) |
| **F-20** | `"`SPOT_ORACLE` rule; per-event provenance missing"` | `"true valuation-source identity per event"` | Line 49 | **EQUAL** (Verbatim) |
| **F-21** | `"raw capture metadata only"` | `"bind request/source/bytes/time/event + coverage"` | Line 50 | **EQUAL** (Verbatim) |
| **F-22** | `"none admitted"` | `"deterministic raw→event digest, source-bound"` | Line 51 | **EQUAL** (Verbatim) |
| **F-23** | `"key absent (not null)"` | `"real **qualified** human review after complete evidence"` | Line 52 | **EQUAL** (Verbatim) |
| **24–27** | `"**four retained shared requirements** (grouped; per-ID ordering unavailable); no canonical production pointers"` | `"derive from completed accepted records"` | Line 53 | **EQUAL** (Verbatim) |

*Table B Completeness: 27 of 27 signed risk items present (5 I + 7 C + 11 F + 4 shared 24–27), quoted verbatim from source matrix.*

---

## (c) Full Citation Verification Table (115 Distinct Path:Line Pairs)

Every single backticked citation in `subject/P012_PRODUCTION_ADMISSION_PACKET.md` was resolved against its staged copy under `sources/` or `subject/` as mapped by `FILE_MAP.md`. All 115 distinct pairs are classified below:

### 1. `03_PRODUCTION_CLOSURE_MATRIX.md` (38 distinct pairs)
*Original path: `C:/Users/BarışSemaay/Documents/Codex/2026-09-11/11-2/outputs/P012_INDEPENDENT_READINESS/03_PRODUCTION_CLOSURE_MATRIX.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 1 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:7` | 102 | `"All ten are disposition APPLICABLE and formally OPEN for production..."` | **EQUAL** |
| 2 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:11` | 80, 92 | `"\| OPEN-01 \| Hyperliquid perp BTC from frozen doc set; record APPROVED..."` | **EQUAL** |
| 3 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:12` | 81, 93 | `"\| OPEN-02 \| STOP_FIRST mandatory same-bar policy..."` | **EQUAL** |
| 4 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:13` | 82, 94 | `"\| OPEN-03 \| fee table v1.1 + ADOPTED CLASS MAPPING..."` | **EQUAL** |
| 5 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:14` | 83, 95 | `"\| OPEN-04 \| BPS_OF_REFERENCE_V1, slippage_bps = 0 explicit zero..."` | **EQUAL** |
| 6 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:15` | 84, 96 | `"\| OPEN-05 \| funding rules APPROVED + same-timestamp snapshot INCLUDE..."` | **EQUAL** |
| 7 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:16` | 85, 97 | `"\| OPEN-06 \| RETAIN ALL P01-P03/P05-P18/P24-P26; P04 RETIRE..."` | **EQUAL** |
| 8 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:17` | 86, 98 | `"\| OPEN-07 \| mapping APPROVED as closure evidence..."` | **EQUAL** |
| 9 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:18` | 87, 99 | `"\| OPEN-08 \| no additional bounds (add. 15 row 33)..."` | **EQUAL** |
| 10 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:19` | 88, 100 | `"\| OPEN-09 \| additive result/event schema (add. 15 row 34)..."` | **EQUAL** |
| 11 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:20` | 89, 101 | `"\| OPEN-10 \| guards keep GROSS-MINUS-FEES (add. 15 row 35)..."` | **EQUAL** |
| 12 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:26` | 109, 272 | `"Numbering preserved. Source: PRIOR_CHECKLIST.md:23-48; residual inventory..."` | **EQUAL** |
| 13 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:30` | 114, 140 | `"\| I-1 \| instrument /status \| addendum-16 selection applied; admission still refused..."` | **EQUAL** |
| 14 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:31` | 115, 141 | `"\| I-2 \| /price_tick \| scalar null; typed policy HYPERLIQUID_PX_V1 implemented..."` | **EQUAL** |
| 15 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:32` | 116, 142 | `"\| I-3 \| /minimum_quantity \| null; minimum_notional: 10, quantity_step: 0.00001..."` | **EQUAL** |
| 16 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:33` | 117, 143, 207 | `"\| I-4 \| instrument human reviewer \| human_reviewer: null (key present)..."` | **EQUAL** |
| 17 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:34` | 118, 144 | `"\| I-5 \| aggregate source fingerprint \| implemented + verified..."` | **EQUAL** |
| 18 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:35` | 119, 145 | `"\| C-6 \| cost effective interval \| start implemented (2026-09-06T14:00:30Z)..."` | **EQUAL** |
| 19 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:36` | 120, 146 | `"\| C-7 \| fee rounding rule \| KEEP_REFUSED; absence proof attached..."` | **EQUAL** |
| 20 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:37` | 121, 147 | `"\| C-8 \| fixed component \| KEEP_REFUSED; absence proof..."` | **EQUAL** |
| 21 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:38` | 122, 148 | `"\| C-9 \| minimum fee \| KEEP_REFUSED; absence proof..."` | **EQUAL** |
| 22 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:39` | 123, 149, 223 | `"\| C-10 \| account tier evidence \| collected, not incorporated..."` | **EQUAL** |
| 23 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:40` | 124, 150 | `"\| C-11 \| liquidation class \| CANNOT_MAP refusal (MARGIN_CALL_LIQUIDATION)..."` | **EQUAL** |
| 24 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:41` | 125, 151, 208 | `"\| C-12 \| cost human reviewer \| key absent (not null)..."` | **EQUAL** |
| 25 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:42` | 126, 152, 230 | `"\| F-13 \| funding effective interval \| null \| complete period + interval semantics..."` | **EQUAL** |
| 26 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:43` | 127, 153 | `"\| F-14 \| funding events \| null; REFUSED_MISSING_PRODUCTION_FUNDING_EVENTS..."` | **EQUAL** |
| 27 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:44` | 128, 154 | `"\| F-15 \| event timestamp \| 4 raw stamps (+31–53 ms) collected, not admitted..."` | **EQUAL** |
| 28 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:45` | 129, 155 | `"\| F-16 \| funding event ID \| none admitted \| source-bound unique identity..."` | **EQUAL** |
| 29 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:46` | 130, 156 | `"\| F-17 \| raw rate \| 4 rows 0.0000125, not admitted..."` | **EQUAL** |
| 30 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:47` | 131, 157 | `"\| F-18 \| positive-rate payer \| LONG rule implemented; no per-event objects..."` | **EQUAL** |
| 31 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:48` | 132, 158 | `"\| F-19 \| oracle price \| 3 samples; no settlement valuation..."` | **EQUAL** |
| 32 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:49` | 133, 159 | `"\| F-20 \| oracle price source \| SPOT_ORACLE rule; per-event provenance missing..."` | **EQUAL** |
| 33 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:50` | 134, 160 | `"\| F-21 \| event provenance \| raw capture metadata only..."` | **EQUAL** |
| 34 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:51` | 135, 161 | `"\| F-22 \| source event digest \| none admitted \| deterministic raw→event digest..."` | **EQUAL** |
| 35 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:52` | 136, 162, 209 | `"\| F-23 \| funding human reviewer \| key absent (not null)..."` | **EQUAL** |
| 36 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:53` | 110, 137, 163, 275 | `"\| 24–27 \| run-manifest digests + effective intervals \| four retained shared requirements..."` | **EQUAL** |
| 37 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:59` | 103 | `"- Human review contract preserved exactly. OPEN-01 expressly references..."` | **EQUAL** |
| 38 | `.../03_PRODUCTION_CLOSURE_MATRIX.md:62` | 104 | `"- Overlap (27 risks vs 10 OPEN rows) is mapped, not counted as closure..."` | **EQUAL** |

---

### 2. `P012_ACCEPTANCE_AMENDMENT_20260913.md` (19 distinct pairs)
*Original path: `C:/CT13/MTC_COMMAND_CENTER/00_AGENT_PROTOCOLS/CLAUDE_TAKEOVER_20260913/P012_ACCEPTANCE_AMENDMENT_20260913.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 39 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:3` | 263 | `"Status: RECORDED AMENDMENT / NONACCEPTING. The owner approved..."` | **EQUAL** |
| 40 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:28` | 6 | `"- Class B — explicitly open production-admission follow-up. Class B rows are not closed,"` | **EQUAL** |
| 41 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:29` | 7 | `"  waived, weakened or reinterpreted by this amendment. Each carries its evidence requirement..."` | **EQUAL** |
| 42 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:32` | 8 | `"A row being Class B never means "resolved"; it means "outside the narrowed acceptance object..."` | **EQUAL** |
| 43 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:33` | 9 | `"still open". No Class B row may be declared closed by the label in §1."` | **EQUAL** |
| 44 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:144` | 164, 179, 199, 212 | `"\| SPECIALIST \| CT13/…/REVIEW_POLICY.md:73-76... \| Bounded specialist review for the first kernel..."` | **EQUAL** |
| 45 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:202` | 165, 177, 190, 240 | `"\| PD-B3 \| …SIGNED_20260912.md:7... \| Choice B3 = B — "Amend the start to the first authenticated own-account fill"..."` | **EQUAL** |
| 46 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:203` | 166, 177, 191, 241 | `"\| PD-B3-FILL \| ... \| The first-authenticated-fill fee boundary itself: "The fee-evidence interval begins..."` | **EQUAL** |
| 47 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:211` | 55, 167, 178, 193, 234 | `"\| PD-FUND-START \| ... \| Funding interval lower bound: "The whole declared funding interval must begin at or after 2026-09-12T11:00:00Z"..."` | **EQUAL** |
| 48 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:212` | 168, 179, 200 | `"\| PD-MONEY-GATE \| ... \| "the experienced-human money gate is separate"..."` | **EQUAL** |
| 49 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:337` | 224 | `"4. ASSUMPTION — base tier-0 selection. tier_selection_basis is"` | **EQUAL** |
| 50 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:338` | 225 | `"   OWNER_APPROVED_BASE_TIER_0_WITH_ACCOUNT_EVIDENCE_RESIDUAL; account-tier evidence is collected"` | **EQUAL** |
| 51 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:339` | 226 | `"   but not incorporated (…BASE-TIER0-V2.json:93; C-10)."` | **EQUAL** |
| 52 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:367` | 68, 283 | `"    position value"; settlement cadence is not established"` | **EQUAL** |
| 53 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:375` | 174, 182, 269, 273 | `"17. ASSUMPTION — counts quoted, not recomputed. "27 signed risks", "five residual obligations"..."` | **EQUAL** |
| 54 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:395` | 276 | `"3. Risks 24-27 are not individually identified anywhere I read. The matrix groups them as"` | **EQUAL** |
| 55 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:396` | 277 | `"   "four retained shared requirements (grouped; per-ID ordering unavailable)" (:53). §2 therefore"` | **EQUAL** |
| 56 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:397` | 278 | `"   carries four rows R-24..R-27 whose per-ID content is not established. Only 23 of the 27"` | **EQUAL** |
| 57 | `.../P012_ACCEPTANCE_AMENDMENT_20260913.md:403` | 174, 183, 270 | `"5. The five residual obligations are nowhere enumerated under that name. Sources give counts"` | **EQUAL** |

---

### 3. `PATH_D_DECISION_PACKET.md` (18 distinct pairs)
*Original path: `C:/LAB/Tradingview_LAB_CLEAN/_gemini_packets_20260913/P012_S16_G5_ONLY/AUTHORITY/PATH_D/PATH_D_DECISION_PACKET.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 58 | `.../PATH_D_DECISION_PACKET.md:25` | 44, 218 | `""Path 1" (self-observation on the owner's own account) is the complement: it supplies real instances..."` | **EQUAL** |
| 59 | `.../PATH_D_DECISION_PACKET.md:47` | 60 | `"Current status. Control-table row Funding F13–22 / OPEN05,07 — BLOCKED: production funding events..."` | **EQUAL** |
| 60 | `.../PATH_D_DECISION_PACKET.md:61` | 61 | `"- Refusals kept: no oracle value is admitted, derived or back-calculated [FF:80]..."` | **EQUAL** |
| 61 | `.../PATH_D_DECISION_PACKET.md:63` | 62, 178, 194 | `"- Evidence still required before admission: authenticated capture bytes with a digest domain..."` | **EQUAL** |
| 62 | `.../PATH_D_DECISION_PACKET.md:64` | 63, 66, 281 | `"- Residual risk: the Bridge accepts the venue's arithmetic without any independent revaluation..."` | **EQUAL** |
| 63 | `.../PATH_D_DECISION_PACKET.md:70` | 52, 178, 192, 232 | `"\| A1 \| Admission window \| Forward-only: only settlements captured live on the owner's own account..."` | **EQUAL** |
| 64 | `.../PATH_D_DECISION_PACKET.md:71` | 53, 176, 188, 233 | `"\| A2 \| Magnitude guard \| No cap \| Cap at M × the largest own-account observed rate..."` | **EQUAL** |
| 65 | `.../PATH_D_DECISION_PACKET.md:90` | 255 | `"- Source classes: HL_FEE_REPORTED_PER_FILL_V1 (admitted cost) + HL_FEE_SCHEDULE_ESTIMATOR_GUARDED_V1..."` | **EQUAL** |
| 66 | `.../PATH_D_DECISION_PACKET.md:91` | 256 | `"- Admitted inputs: the venue's own reported fee string on the owner's authenticated fill..."` | **EQUAL** |
| 67 | `.../PATH_D_DECISION_PACKET.md:92` | 257 | `"- Refusals kept: the literal EXACT_IDENTITY_V1 is never written..."` | **EQUAL** |
| 68 | `.../PATH_D_DECISION_PACKET.md:93` | 258 | `"- Guard margins: the estimator (taker 0.00045 / maker 0.00015 [FEE:61]) is computed alongside..."` | **EQUAL** |
| 69 | `.../PATH_D_DECISION_PACKET.md:94` | 58, 175, 186 | `"- Evidence still required before admission: N authenticated own-account native-BTC fills..."` | **EQUAL** |
| 70 | `.../PATH_D_DECISION_PACKET.md:103` | 54, 177, 189, 239 | `"\| B3 \| Effective interval start \| Keep 2026-09-06T14:00:30Z... \| Amend the start to the first authenticated fill..."` | **EQUAL** |
| 71 | `.../PATH_D_DECISION_PACKET.md:164` | 179, 198 | `"Exact review roster (T0). Fresh exact claude-opus-5 and gpt-5.6-sol, both xhigh..."` | **EQUAL** |
| 72 | `.../PATH_D_DECISION_PACKET.md:191` | 46, 265 | `"Standing exclusions, unchanged by this signature"` | **EQUAL** |
| 73 | `.../PATH_D_DECISION_PACKET.md:192` | 47, 266 | `" - No deploy, live trading, TESTNET/mainnet contact, ARM, order placement, wallet or transfer"` | **EQUAL** |
| 74 | `.../PATH_D_DECISION_PACKET.md:193` | 48, 267 | `"   authority arises from this document. Path 1 needs its own separate explicit authorization."` | **EQUAL** |
| 75 | `.../PATH_D_DECISION_PACKET.md:250` | 67, 282 | `"Where sources are silent (not filled in anywhere above): the funding settlement formula and cadence..."` | **EQUAL** |

---

### 4. `06_HYPERLIQUID_SETUP.md` (10 distinct pairs)
*Original path: `C:/CT13/IBKR_PAPER_BRIDGE/docs/06_HYPERLIQUID_SETUP.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 76 | `.../06_HYPERLIQUID_SETUP.md:1` | 18 | `"# 06 — Hyperliquid Setup Checklist (testnet = paper)"` | **EQUAL** |
| 77 | `.../06_HYPERLIQUID_SETUP.md:14` | 19 | `"\| \| Testnet (paper) \| Mainnet (real money) \|"` | **EQUAL** |
| 78 | `.../06_HYPERLIQUID_SETUP.md:16` | 20, 216 | `"\| Money \| Fake (faucet USDC) \| Real \|"` | **EQUAL** |
| 79 | `.../06_HYPERLIQUID_SETUP.md:19` | 21, 217 | `"\| Use for \| ALL of v1 (P0-P3) \| never in v1 \|"` | **EQUAL** |
| 80 | `.../06_HYPERLIQUID_SETUP.md:21` | 22 | `"Do everything below on testnet."` | **EQUAL** |
| 81 | `.../06_HYPERLIQUID_SETUP.md:37` | 24 | `"Do NOT put your main wallet private key in the bridge. Hyperliquid supports API wallets"` | **EQUAL** |
| 82 | `.../06_HYPERLIQUID_SETUP.md:38` | 25 | `"(a.k.a. agent wallets): a delegated key that can place/cancel orders but cannot withdraw funds."` | **EQUAL** |
| 83 | `.../06_HYPERLIQUID_SETUP.md:45` | 26 | `"4. The bridge signs orders with the API wallet key and references the main account address..."` | **EQUAL** |
| 84 | `.../06_HYPERLIQUID_SETUP.md:46` | 27 | `"   the API wallet cannot withdraw, even a fully compromised bridge cannot move your funds..."` | **EQUAL** |
| 85 | `.../06_HYPERLIQUID_SETUP.md:47` | 28 | `"   the single most important safety property — never use the main wallet key."` | **EQUAL** |

---

### 5. `COMMANDS.md` (8 distinct pairs)
*Original path: `C:/CT13/IBKR_PAPER_BRIDGE/deploy/linux/COMMANDS.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 86 | `.../COMMANDS.md:98` | 36 | `"Gate: KVM2-P4-03 — owner-only, separate from P4-01/P4-02, TESTNET only."` | **EQUAL** |
| 87 | `.../COMMANDS.md:100` | 37 | `"Not scripted here on purpose. The values are typed by the owner into"` | **EQUAL** |
| 88 | `.../COMMANDS.md:101` | 38 | `"/etc/mtc-bridge/mtc-bridge.env (already 0600 root:root) through an editor on"` | **EQUAL** |
| 89 | `.../COMMANDS.md:102` | 39 | `"a trusted session. Names are listed in env/mtc-bridge.env.template."` | **EQUAL** |
| 90 | `.../COMMANDS.md:104` | 286 | `"Post-conditions to assert afterwards, values never printed:"` | **EQUAL** |
| 91 | `.../COMMANDS.md:263` | 40, 249 | `"ARM (KVM2-P5-05/P5-05A), monitoring and backup provider provisioning"` | **EQUAL** |
| 92 | `.../COMMANDS.md:265` | 41, 250 | `"mainnet action. Each needs its own owner sentence, and none of them is implied"` | **EQUAL** |
| 93 | `.../COMMANDS.md:266` | 42, 251 | `"by completing every stage above."` | **EQUAL** |

---

### 6. `DEPLOY_LINUX_README.md` (6 distinct pairs)
*Original path: `C:/CT13/IBKR_PAPER_BRIDGE/deploy/linux/README.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 94 | `.../DEPLOY_LINUX_README.md:137` | 30, 288 | `"## Gate order (none of which this directory grants)"` | **EQUAL** |
| 95 | `.../DEPLOY_LINUX_README.md:141` | 31, 245 | `"3. KVM2-P4-03 — owner separately authorizes TESTNET-only secret provisioning."` | **EQUAL** |
| 96 | `.../DEPLOY_LINUX_README.md:145` | 32, 246 | `"5. KVM2-P4-06 — owner authorizes exactly one first DISARMED start;"` | **EQUAL** |
| 97 | `.../DEPLOY_LINUX_README.md:146` | 33 | `"   KVM2-P4-07 executes it once (systemctl unmask then systemctl start)."` | **EQUAL** |
| 98 | `.../DEPLOY_LINUX_README.md:147` | 34, 247 | `"6. KVM2-P4-08 — rollback proof. KVM2-P4-08A/B — any recovery start."` | **EQUAL** |
| 99 | `.../DEPLOY_LINUX_README.md:148` | 35, 248 | `"7. KVM2-P5-05/P5-05A — ARM, separately, once, never implied by any of the above."` | **EQUAL** |

---

### 7. `MASTER_WORK_PACKAGE_excerpt.md` (5 distinct pairs)
*Original path: `C:/CT13/MTC_COMMAND_CENTER/11_TRIAGE/MASTER_WORK_PACKAGE_AND_PARALLEL_DELIVERY_PLAN_2026-08-22.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 100 | `.../MASTER_WORK_PACKAGE_excerpt.md:400` | 70, 289 | `"### WP-P0-12 · Kernel CORRECTED_VNEXT (M7b)"` | **EQUAL** |
| 101 | `.../MASTER_WORK_PACKAGE_excerpt.md:405` | 71 | `"- Protected surfaces: the strategy kernel. · Audit tier: T0."` | **EQUAL** |
| 102 | `.../MASTER_WORK_PACKAGE_excerpt.md:406` | 72, 290 | `"- Acceptance gate: no undocumented behavioural difference exists between P0-11 and P0-12..."` | **EQUAL** |
| 103 | `.../MASTER_WORK_PACKAGE_excerpt.md:407` | 73 | `"- Non-goals: no new features; no optimization; no runtime wiring."` | **EQUAL** |
| 104 | `.../MASTER_WORK_PACKAGE_excerpt.md:1069` | 74 | `"\| G3-K — Kernel, canonical simulator... \| WP-P0-09, WP-P0-10, WP-P0-11, WP-P0-12, WP-P0-20..."` | **EQUAL** |

---

### 8. `REVIEW_POLICY.md` (4 distinct pairs)
*Original path: `C:/CT13/MTC_COMMAND_CENTER/00_AGENT_PROTOCOLS/REVIEW_POLICY.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 105 | `.../REVIEW_POLICY.md:73` | 10, 179, 195 | `"Add a bounded specialist review for the first kernel, first live release, major security change,"` | **EQUAL** |
| 106 | `.../REVIEW_POLICY.md:74` | 11, 179, 196, 210 | `"or serious unresolved disagreement; name the question and stop condition. An experienced engineer"` | **EQUAL** |
| 107 | `.../REVIEW_POLICY.md:75` | 12, 179, 197, 211 | `"reviews before the first money-exposed release, not every package. These checks do not confer"` | **EQUAL** |
| 108 | `.../REVIEW_POLICY.md:76` | 13 | `"live-trading authority or replace exact protected acceptance contracts."` | **EQUAL** |

---

### 9. `TASK.md` (3 distinct pairs)
*Original path: `C:/tmp/P012_RISK_20260914/TASK.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 109 | `.../TASK.md:11` | 17 | `"...The owner said "TESTNET GO" today... KVM2 status at 08:40Z: service active, DISARMED..."` | **EQUAL** |
| 110 | `.../TASK.md:13` | 285 | `"- Do NOT read or quote any credential, wallet address, key or .env value. Everything here is documentary."` | **EQUAL** |
| 111 | `.../TASK.md:17` | 65, 280 | `"2. The evidence pipeline in plain steps: what TESTNET GO starts; what a testnet capture can and cannot satisfy..."` | **EQUAL** |

---

### 10. `PATH_D_DECISION_SIGNED_20260912.md` (3 distinct pairs)
*Original path: `C:/LAB/Tradingview_LAB_CLEAN/_gemini_packets_20260913/P012_S16_G5_ONLY/AUTHORITY/PATH_D/PATH_D_DECISION_SIGNED_20260912.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 112 | `.../PATH_D_DECISION_SIGNED_20260912.md:6` | 50, 176, 178, 187, 231 | `"A. Funding APPROVE A1=A A2=B (M PENDING, separate decision after N observations) A3=A"` | **EQUAL** |
| 113 | `.../PATH_D_DECISION_SIGNED_20260912.md:7` | 51, 57, 175, 177, 185, 238 | `"B. Fees APPROVE B1=C B2=C (5% rel; alt max(5%, 1e-6 USDC)) B3=B B4=A N=3 (maker, taker, near-$10)"` | **EQUAL** |
| 114 | `.../PATH_D_DECISION_SIGNED_20260912.md:11` | 45, 219, 264 | `"no deploy/live/TESTNET/mainnet/ARM/order/spend authority; T0 reviews, R29 redo, ratification, CI, protected merge remain."` | **EQUAL** |

---

### 11. `P012_RATIFICATION_LEAD_NOTE.md` (1 distinct pair)
*Original path: `C:/CT13/MTC_COMMAND_CENTER/00_AGENT_PROTOCOLS/CLAUDE_TAKEOVER_20260913/P012_RATIFICATION_APPLIED_20260914/LEAD_NOTE.md`*

| # | Cited Path:Line | Packet Occurrence Line(s) | Quoted Content / Content on Line | Classification |
|---|---|---|---|---|
| 115 | `.../P012_RATIFICATION_LEAD_NOTE.md:10` | 5, 174, 175, 176, 184 | `"- Production admission is NOT granted. All 10 Section-19 OPEN rows, the 27 signed risks, the five residual obligations..."` | **EQUAL** |

---

*Summary of Citation Classification: 115 EQUAL, 0 WRONG LINE, 0 NOT FOUND (100% accuracy).*

---

## (d) New Findings

**None.**
All previously flagged issues (F-01 through F-09) have been resolved completely in `subject/P012_PRODUCTION_ADMISSION_PACKET.md`. The newly staged files, the expanded section 6 decisions, and Table C contain zero invented citations, zero hedge upgrades, and zero unsupported claims.

---

## (e) Exact Read Coverage with Ranges and Continuations

All reads were performed strictly via the native `view_file` tool on local filesystem paths inside `C:/LAB/Tradingview_LAB_CLEAN/_gemini_packets_20260913/P012_RISK_PACKET_20260914_B/` (with initial governance read of root `AGENTS.md`), strictly respecting `<= 150` lines per view:

1. `C:/LAB/Tradingview_LAB_CLEAN/AGENTS.md` (Lines 1–64; 64 lines) — Complete read.
2. `.../PACKET_SHA256SUMS.txt` (Lines 1–19; 19 lines) — Complete read.
3. `.../FILE_MAP.md` (Lines 1–17; 17 lines) — Complete read.
4. `.../subject/DISPOSITION_FIX1.md` (Lines 1–13; 13 lines) — Complete read.
5. `.../subject/TASK_FIX1.md` (Lines 1–19; 19 lines) — Complete read.
6. `.../subject/TASK.md` (Lines 1–27; 27 lines) — Complete read.
7. `.../prior/GEMINI_AUDIT_1_REPORT.md` (Lines 309–389; 81 lines) — Required range read.
8. `.../prior/GEMINI_AUDIT_1_REPORT.md` (Lines 424–446; 23 lines) — Required range read.
9. `.../subject/P012_PRODUCTION_ADMISSION_PACKET.md` (Lines 1–150; 150 lines) — Part 1 read.
10. `.../subject/P012_PRODUCTION_ADMISSION_PACKET.md` (Lines 151–291; 141 lines) — Continuation 1 (complete file to line 291).
11. `.../sources/03_PRODUCTION_CLOSURE_MATRIX.md` (Lines 1–65; 65 lines) — Part 1 read.
12. `.../sources/03_PRODUCTION_CLOSURE_MATRIX.md` (Lines 65–66; 2 lines) — Continuation 1 (complete file to line 66).
13. `.../sources/PATH_D_DECISION_SIGNED_20260912.md` (Lines 1–19; 19 lines) — Part 1 read.
14. `.../sources/PATH_D_DECISION_SIGNED_20260912.md` (Line 20; 1 line) — Continuation 1 (complete file to line 20).
15. `.../sources/REVIEW_POLICY.md` (Lines 1–76; 76 lines) — Part 1 read.
16. `.../sources/REVIEW_POLICY.md` (Line 77; 1 line) — Continuation 1 (complete file to line 77).
17. `.../sources/06_HYPERLIQUID_SETUP.md` (Lines 1–112; 112 lines) — Part 1 read.
18. `.../sources/06_HYPERLIQUID_SETUP.md` (Line 113; 1 line) — Continuation 1 (complete file to line 113).
19. `.../sources/DEPLOY_LINUX_README.md` (Lines 130–148; 19 lines) — Required range read.
20. `.../sources/COMMANDS.md` (Lines 96–105; 10 lines) — Required range read.
21. `.../sources/COMMANDS.md` (Lines 258–266; 9 lines) — Required range read.
22. `.../sources/MASTER_WORK_PACKAGE_excerpt.md` (Lines 1–38; 38 lines) — Complete read.
23. `.../sources/P012_RATIFICATION_LEAD_NOTE.md` (Lines 1–10; 10 lines) — Part 1 read.
24. `.../sources/P012_RATIFICATION_LEAD_NOTE.md` (Line 11; 1 line) — Continuation 1 (complete file to line 11).
25. `.../sources/P012_ACCEPTANCE_AMENDMENT_20260913.md` (Lines 1–50; 50 lines) — Covers cited lines 3, 28, 29, 32, 33.
26. `.../sources/P012_ACCEPTANCE_AMENDMENT_20260913.md` (Lines 140–220; 81 lines) — Covers cited lines 144, 202, 203, 211, 212.
27. `.../sources/P012_ACCEPTANCE_AMENDMENT_20260913.md` (Lines 335–410; 76 lines) — Covers cited lines 337, 338, 339, 367, 375, 395, 396, 397, 403.
28. `.../sources/PATH_D_DECISION_PACKET.md` (Lines 20–110; 91 lines) — Covers cited lines 25, 47, 61, 63, 64, 70, 71, 90, 91, 92, 93, 94, 103.
29. `.../sources/PATH_D_DECISION_PACKET.md` (Lines 160–255; 96 lines) — Covers cited lines 164, 191, 192, 193, 250.
30. `.../subject/SHA256SUMS.txt` (Lines 1–3; 3 lines) — Complete read.
31. `.../prior/LEAD_ADJUDICATION_AUDIT_1.md` (Lines 1–8; 8 lines) — Complete read.

*Required Scope Unread: NONE.*

---

## (f) Nonempty NOT VERIFIED

The following items are confirmed as correctly recorded under Section 7 of the packet and are independently corroborated as **NOT VERIFIED** (hedges, counts, or unresolved absences):

1. **Hyperliquid Funding Settlement Cadence:** Not verified in repository sources. While the writer brief noted an 8-hour cadence assumption, `PATH_D_DECISION_PACKET.md:64, 250` and `P012_ACCEPTANCE_AMENDMENT_20260913.md:367` explicitly record that settlement cadence is *not established* in the inspected source set. The packet correctly identifies cadence as NOT VERIFIED rather than adopting an unverified assumption.
2. **Enumeration of Five Residual Obligations:** Not verified as an enumerated list. As stated in `P012_ACCEPTANCE_AMENDMENT_20260913.md:375, 403`, the five residual obligations are counted only (`"five residual obligations"`), never enumerated under that name in any authoritative source.
3. **Per-ID Content of Signed Risks 24–27:** Not verified as individual identifiers. As recorded in `03_PRODUCTION_CLOSURE_MATRIX.md:53` and `P012_ACCEPTANCE_AMENDMENT_20260913.md:395-397`, the matrix groups them as "four retained shared requirements (grouped; per-ID ordering unavailable)"; per-ID ordering and individual identities are unavailable.
4. **27 Signed Risk Count:** Quoted from matrix arithmetic (`5 (I) + 7 (C) + 11 (F) + 4 shared = 27`) and amendment assumption 17 (`P012_ACCEPTANCE_AMENDMENT_20260913.md:375`), not independently recomputed from primary unmerged sources.
5. **No Credentials / Wallets / Keys:** Explicitly excluded from read scope per `TASK.md:13` and confirmed unquoted.

---

## (g) Audit Verdict JSON

```json
{
  "part": "P012_RISK_PACKET_GEMINI_B2",
  "verdict": "PASS",
  "evidence_class": "SUPPLEMENTAL_UNEXECUTED",
  "delta": {
    "F-01": "RESOLVED",
    "F-02": "RESOLVED",
    "F-03": "RESOLVED",
    "F-04": "RESOLVED",
    "F-05": "RESOLVED",
    "F-06": "RESOLVED",
    "F-07": "RESOLVED",
    "F-08": "RESOLVED",
    "F-09": "RESOLVED"
  },
  "findings": [],
  "required_scope_unread": []
}
```

GEMINI_READ_ONLY_OK
